VEEV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Veeva Systems Inc. (VEEV) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company demonstrates solid financial growth and has positive analyst sentiment, the technical indicators suggest a bearish trend, and the options data reflects a cautious trading sentiment. Given the investor's impatience and unwillingness to wait for optimal entry points, holding off on purchasing VEEV right now is recommended.
The technical indicators for VEEV show a bearish trend. The MACD is negative and contracting (-2.429), the RSI is neutral at 20.452, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot point of 185.824, with support at 171.894 and resistance at 199.753.
Strong financial performance in Q3 2026, with revenue up 16.02% YoY, net income up 27.12% YoY, and EPS up 23.89% YoY.
Analysts maintain positive sentiment, with several 'Buy' and 'Outperform' ratings, citing durable growth, margin stability, and attractive valuations.
Veeva's product-led growth narrative and strong execution in growth areas like Crossix and AI traction.
The technical indicators suggest a bearish trend, with the stock trading below its pivot point and moving averages.
Options data reflects cautious sentiment, with a high put-call volume ratio and elevated implied volatility.
Broader concerns in the software sector due to AI disruption fears, as highlighted by recent news.
In Q3 2026, Veeva Systems Inc. reported strong financials: Revenue increased by 16.02% YoY to $811.24M, net income grew by 27.12% YoY to $236.2M, and EPS rose by 23.89% YoY to 1.4. Gross margin improved slightly to 75.41%.
Analysts maintain a positive outlook on VEEV, with several 'Buy' and 'Outperform' ratings. Recent price target adjustments reflect cautious optimism, with targets ranging from $275 to $333. Analysts highlight durable growth, margin stability, and attractive valuations despite competitive risks in the healthcare technology space.
